HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas E Witzig Selected Research

Necrosis

1/2017Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma.
12/2012Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.
12/2004Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.
10/2003Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas E Witzig Research Topics

Disease

84Neoplasms (Cancer)
05/2024 - 02/2002
65Lymphoma (Lymphomas)
05/2024 - 01/2002
63Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 01/2002
38Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2022 - 07/2007
35Multiple Myeloma
01/2021 - 11/2002
26Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2024 - 06/2002
19Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2023 - 05/2005
19Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 01/2002
18B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2024 - 11/2002
13Disease Progression
01/2020 - 09/2002
12Infections
05/2024 - 06/2002
12Hodgkin Disease (Hodgkin's Disease)
01/2024 - 10/2005
12Immunoglobulin Light-chain Amyloidosis
06/2014 - 02/2003
11B-Cell Lymphoma (Lymphoma, B Cell)
04/2024 - 01/2002
10Thrombocytopenia (Thrombopenia)
08/2017 - 06/2002
7Neutropenia
05/2022 - 01/2007
5Fatigue
05/2022 - 04/2005
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 04/2003
5Colonic Neoplasms (Colon Cancer)
03/2007 - 09/2003
4Acute Kidney Injury (Acute Renal Failure)
02/2024 - 09/2021
4Febrile Neutropenia
05/2022 - 07/2005
4Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 07/2006
4Immunoglobulin G4-Related Disease
12/2018 - 06/2015
4Anemia
08/2017 - 01/2003
4Necrosis
01/2017 - 10/2003
4Smoldering Multiple Myeloma
01/2016 - 08/2004
4Paraproteinemias (Monoclonal Gammopathy)
12/2012 - 01/2002
4Autoimmune Diseases (Autoimmune Disease)
01/2011 - 09/2003
4Carcinoma (Carcinomatosis)
03/2007 - 05/2002
3Sepsis (Septicemia)
04/2021 - 06/2002
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 09/2007
3T-Cell Lymphoma (Lymphoma, T Cell)
07/2015 - 10/2009
3Genetic Translocation (Chromosomal Translocation)
01/2015 - 09/2013
3POEMS Syndrome (Syndrome, POEMS)
07/2013 - 04/2003
3Chromosome Aberrations (Chromosome Abnormalities)
02/2011 - 05/2003
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2008 - 06/2004
2COVID-19
04/2024 - 06/2023
2Diarrhea
05/2022 - 03/2013

Drug/Important Bio-Agent (IBA)

53Rituximab (Mabthera)FDA Link
01/2024 - 01/2002
24Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2007
23Proteins (Proteins, Gene)FDA Link
04/2024 - 04/2003
21ibritumomab tiuxetan (Zevalin)FDA Link
01/2023 - 02/2002
16Dexamethasone (Maxidex)FDA LinkGeneric
11/2018 - 11/2002
13CytokinesIBA
04/2024 - 08/2004
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 08/2011
11TOR Serine-Threonine KinasesIBA
01/2019 - 08/2005
11EverolimusFDA Link
10/2018 - 07/2006
10Immunoglobulin M (IgM)IBA
01/2020 - 01/2002
10Monoclonal AntibodiesIBA
10/2008 - 08/2003
9Biomarkers (Surrogate Marker)IBA
07/2022 - 12/2006
8Methotrexate (Mexate)FDA LinkGeneric
02/2024 - 06/2004
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2005
8Immunoglobulins (Immunoglobulin)IBA
11/2018 - 04/2006
8Thalidomide (Thalomid)FDA Link
10/2010 - 11/2002
7Yttrium-90IBA
01/2023 - 08/2002
7Prednisone (Sone)FDA LinkGeneric
01/2021 - 10/2011
7YttriumIBA
07/2013 - 02/2002
6ibrutinibIBA
10/2021 - 01/2017
6Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2005
6Cyclin D1IBA
10/2020 - 08/2005
6Bortezomib (Velcade)FDA Link
01/2020 - 07/2005
6Mechanistic Target of Rapamycin Complex 1IBA
10/2018 - 10/2009
6temsirolimusFDA Link
04/2011 - 08/2005
5AnthracyclinesIBA
04/2024 - 08/2014
5B-Cell Activating FactorIBA
05/2009 - 02/2006
4Anti-Bacterial Agents (Antibiotics)IBA
05/2024 - 06/2002
4Immune Checkpoint InhibitorsIBA
01/2024 - 03/2016
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2006
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019 - 07/2006
4LigandsIBA
01/2017 - 02/2008
4Sirolimus (Rapamycin)FDA Link
03/2012 - 07/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 08/2004
4MTOR InhibitorsIBA
04/2011 - 10/2009
4CD20 AntigensIBA
03/2008 - 01/2006
3Messenger RNA (mRNA)IBA
01/2023 - 08/2005
3Bendamustine HydrochlorideFDA Link
01/2022 - 08/2018
3InterferonsIBA
01/2022 - 09/2012
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2021 - 03/2007
3TroponinIBA
01/2019 - 09/2004
3SteroidsIBA
12/2018 - 03/2008
3Immunoglobulin G (IgG)IBA
04/2016 - 03/2008
3Alemtuzumab (Campath)FDA Link
01/2015 - 08/2003
3Complement System Proteins (Complement)IBA
09/2012 - 10/2008
3Vitamin DFDA LinkGeneric
07/2012 - 09/2010
3Interleukin-12 (IL 12)IBA
04/2012 - 01/2002
3Interleukin-10 (Interleukin 10)IBA
03/2012 - 10/2009
3Interleukin-6 (Interleukin 6)IBA
11/2011 - 10/2003
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2010 - 05/2003
3Phosphotransferases (Kinase)IBA
08/2008 - 05/2003
2Biological FactorsIBA
01/2024 - 09/2012
2Radioisotopes (Radionuclides)IBA
08/2023 - 07/2011
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2022 - 11/2012

Therapy/Procedure

89Therapeutics
05/2024 - 01/2002
27Radioimmunotherapy
01/2024 - 02/2002
23Drug Therapy (Chemotherapy)
01/2022 - 06/2002
11Stem Cell Transplantation
01/2022 - 12/2002
8Radiotherapy
05/2024 - 12/2003
7Aftercare (After-Treatment)
02/2024 - 04/2003
6Immunotherapy
01/2024 - 05/2002
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2006 - 05/2004